Regions Financial Corp Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Regions Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	BUY	$83.14 - $145.99 $48,553 - $85,258	584 Added 33.51%	2,327 $339,000
Q1 2022 Apr 25, 2022	BUY	$110.08 - $142.92 $191,869 - $249,109	1,743 New	1,743 $206,000
Q2 2019 Jul 19, 2019	SELL	$39.79 - $67.01 $3,979 - $6,701	-100 Closed	0 $0
Q4 2017 Jan 18, 2018	BUY	$20.44 - $35.56 $2,044 - $3,556	100	100 $3,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Regions Financial Corp with notifications on news.